Immunome Awarded Department of Defense Contract to Develop Biosynthetic Convalescent Plasma for COVID-19
Up to $13.3M funding to accelerate development and early clinical testing of antibodies derived from large-scale B cell interrogation of COVID-19 “Super-Responders”   

See more here